Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novartis Ag ADR (NY: NVS )

84.36 -0.17 (-0.20%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,811,991
Open 83.27
Bid (Size) 81.79 (1)
Ask (Size) 85.32 (1)
Prev. Close 84.53
Today's Range 83.07 - 84.37
52wk Range 79.09 - 95.17
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Celldex Therapeutics Skids As It Takes On A Blockbuster Roche, Novartis Drug
The study was in 26 patients with chronic hives that don't respond to antihistamines. 
Via Investor's Business Daily
Cough Remedies Market 2022-2029 Global Industry Trends, Growth Rate and Revenue : Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis
Global Cough Remedies Market Research 2022-2031 published by Calibre Research studies the current situation, Cough Remedies market size, share, trends, regional growth and the latest technologies... 
Via SBWire
Topics Supply Chain
Exposures Supply Chain

Performance

YTD
-3.99%
-3.99%
1 Month
-5.89%
-5.89%
3 Month
-3.80%
-3.80%
6 Month
-3.56%
-3.56%
1 Year
-7.95%
-7.95%

More News

Read More
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
Via Benzinga
Novartis' Tislelizumab Extends Overall Survival In Late-Stage Esophageal Cancer Study
Via Benzinga
Novartis Resumes Production, Delivery Of Radioligand Therapy Medicines
Via Benzinga
Novartis Announces $250M In R&D Funding For Neglected Tropical Diseases, Malaria
Via Benzinga
FDA Gives Approval For Novartis' Tafinlar + Mekinist Broadens BRAF/MEK Cancer Combo Use
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Tigecycline Market Development Factors 2022-2029 Pfizer, Hisun Pharma, Hansoh Pharma, HICIN Pharma, Amgen
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Global Interferon Beta Drugs Market | Key Players are Biogen, Merck, Novartis, Bayer, Faron Pharmaceuticals, and other prominent players
Via iCrowdNewswire
Global Radioligand Therapy Market | Key Players are Johnson & Johnson Services, Inc., Pfizer Inc., Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Amneal Pharmaceuticals LLC, Novartis International AG and many more.
Via iCrowdNewswire
Why Precision BioSciences Shares Are Surging Today
Via Benzinga
Precision BioSciences (DTIL) Stock Treks Higher on Novartis Deal
Via InvestorPlace
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
Via Benzinga
NYSE:NVS Investor Alert: Investigation over Possible Securities Laws Violations by Novartis AG
Via SBWire
Analysts Remain Bullish Despite Caribou's Allogeneic CAR-T Hit By Durability
Via Benzinga
Crews Control Names Barbara Kittridge President, Andrea Keating Moves to CEO
Via Newswire.com
Exposures COVID-19
Sylvester Feddes joins the 2022 Leading Entrepreneurs of the World Conference
Via News Direct
Pfizer's Ibrance Fails To Extend Overall Survival In Newly Diagnosed Breast Cancer Setting
Via Benzinga
NOVARTIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Novartis AG on Behalf of Novartis Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
New effort to standardize cardiovascular care in Mexico, address gaps in care
Via NewMediaWire
2021 R&D Spending and Intensity Benchmarks
Via PRLog
Topics Supply Chain
Exposures Supply Chain
NOVARTIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Novartis AG on Behalf of Novartis Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Novartis AG (NVS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Novartis AG (NVS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.